Gene Polymorphisms for Plasminogen Activator Inhibitor-1/Tissue Plasminogen Activator and Development of Allograft Coronary Artery Disease
- 24 November 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (21) , 2248-2254
- https://doi.org/10.1161/01.cir.98.21.2248
Abstract
Background—Impaired fibrinolytic activity has been linked to the presence and severity of allograft vasculopathy (Tx CAD). This impairment may be associated with the presence of certain fibrinolyti...Keywords
This publication has 18 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery DiseaseJournal of Thrombosis and Thrombolysis, 1998
- Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cellsBlood Coagulation & Fibrinolysis, 1995
- Retinoic Acid Effects on Endothelial Cell Function: Interaction with Interleukin 1Clinical Immunology and Immunopathology, 1994
- Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart diseaseScandinavian Journal of Clinical and Laboratory Investigation, 1994
- Ambient oxygen tension modulates endothelial fibrinolysisJournal of Vascular Surgery, 1993
- Vascular Events in Placentae and Organ AllograftsAmerican Journal of Reproductive Immunology, 1992
- Microvascular Perturbations in Human Allografts: Analogies in Preeclamptic PlacentaeAmerican Journal of Reproductive Immunology, 1992
- Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.Heart, 1988
- Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.Proceedings of the National Academy of Sciences, 1987